Community care in england reducing socioeconomic inequalities in heart failure

Circulation

Volumn 126, Issue 9, 2012, Pages 1050-1057

  Hawkins, Nathaniel M ^a   Scholes, Shaun ^b   Bajekal, Madhavi ^b   Love, Hande ^c   O'Flaherty, Martin ^d   Raine, Rosalind ^b   Capewell, Simon ^d  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Legal and General Assurance Society Ltd   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Heart failure; Inequalities; Social class; Socioeconomic factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; COMMUNITY CARE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS; SURVIVAL RATE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; COMMUNITY HEALTH SERVICES; DRUG UTILIZATION; ENGLAND; FEMALE; HEALTH STATUS INDICATORS; HEALTHCARE DISPARITIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POVERTY; PREVALENCE; SOCIOECONOMIC FACTORS; SPIRONOLACTONE; SURVIVAL RATE;

EID: 84865516578     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.088047     Document Type: Article

References (53)

1. Hawkins NM, Jhund PS, McMurray JJ, Capewell S Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012;14:138-146.
2. Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2006;152:371-378. (Pubitemid 44093389)
3. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119: 515-523.
4. Foraker RE, Rose KM, Suchindran CM, Chang PP, McNeill AM, Rosamond WD Socioeconomic status, Medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: Atherosclerosis Risk in Communities cohort (1987 to 2004). Circ Heart Fail. 2011;4:308-316.
5. Blackledge HM, Tomlinson J, Squire IB Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart. 2003;89:615-620. (Pubitemid 36606202)
6. Shah SM, Carey IM, DeWilde S, Richards N, Cook DG Trends and inequities in 2277;-blocker prescribing for heart failure. Br J Gen Pract. 2008;58:862-869.
7. McAlister FA, Murphy NF, Simpson CR, Stewart S, MacIntyre K, Kirkpatrick M, Chalmers J, Redpath A, Capewell S, McMurray JJ Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. BMJ 2004;328:1110.
8. de Campos Lopes CB, Yamada AT, Araujo F, Pereira Barreto AC, Mansur AJ Socioeconomic factors in the prognosis of heart failure in a Brazilian cohort. Int J Cardiol. 2006;113:181-187. (Pubitemid 44755003)
9. Bongers FJ, Schellevis FG, Bakx C, van den Bosch WJ, van der ZJ Treatment of heart failure in Dutch general practice. BMC Fam Pract. 2006;7:40.
10. Noble M, McLennan D, Wilkinson K, Whitworth A, Exley S, Barnes H, Dibben C The English Indices of Deprivation. Crown Copyright. Department of Communities and Local Government. 2007. http://www. communities.gov.uk/documents/ communities/pdf/733520.pdf. Accessed January 12, 2011.
11. Morgan O, Baker A Measuring deprivation in England and Wales using 2001 Carstairs scores. Health Stat Q 2006;28-33.
12. Walley T, Mantgani A The UK General Practice Research Database. Lancet. 1997;350:1097-1099. (Pubitemid 27437871)
13. Jick H, Jick SS, Derby LE Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768.
14. Hollowell J The General Practice Research Database: quality of morbidity data. Popul Trends. 1997;36-40.
15. Khan NF, Harrison SE, Rose PW Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:199-206.
16. Boyle P, Parkin DM Cancer registration: principles and methods: statistical methods for registries. IARC Scientific Publications. 1991; 126-158.
17. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A Decreasing one-year mortality and hospitalization rates for heart failure in Sweden: data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004;25:300-307. (Pubitemid 38295438)
18. Teng TH, Finn J, Hobbs M, Hung J Heart failure: incidence, case fatality, and hospitalization rates in Western Australia between 1990 and 2005. Circ Heart Fail. 2010;3:236-243.
19. Wasywich CA, Gamble GD, Whalley GA, Doughty RN Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of "days alive and out of hospital" from epidemiological data. Eur J Heart Fail. 2010;12:462-468.
20. Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail. 2011;13:142-147.
21. Curtis LH, Whellan DJ, Hammill BG, Hernandez AF, Anstrom KJ, Shea AM, Schulman KA Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008;168:418-424. (Pubitemid 351350587)
22. Ko DT, Alter DA, Austin PC, You JJ, Lee DS, Qiu F, Stukel TA, Tu JV Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J 2008;155:324-331.
23. Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012;33:314-324.
24. Sheifer SE, Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Breall JA, Schulman KA Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation. 2000;102:1651-1656.
25. Salomaa V, Miettinen H, Niemela M, Ketonen M, Mahonen M, Immonen-Raiha P, Lehto S, Vuorenmaa T, Koskinen S, Palomaki P, Mustaniemi H, Kaarsalo E, Arstila M, Torppa J, Kuulasmaa K, Puska P, Pyorala K, Tuomilehto J Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health. 2001; 55:475-482. (Pubitemid 32591900)
26. Quatromoni J, Jones R Inequalities in socio-economic status and invasive procedures for coronary heart disease: a comparison between the USA and the UK Int J Clin Pract. 2008;62:1910-1919.
27. Dahlgren G, Whitehead M Policies and Strategies to Promote Social Equity and Health. Stockholm, Sweden: Institute of Futures Studies. 1991. http://www.framtidsstudier.se/wp-content/uploads/2011/01/ 20080109110739filmZ8UVQv2wQFShMRF6cuTpdf. Accessed January 12, 2011.
28. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJ, Poole-Wilson PA, Sutton GC Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002;23:877-885. (Pubitemid 34717423)
29. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N Evaluation of the management of heart failure in primary care. Fam Pract. 2009;26: 145-153.
30. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail. 2008;1:98-106.
31. Peterson PN, Rumsfeld JS, Liang L, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA Treatment and risk in heart failure: gaps in evidence or quality? Circ Cardiovasc Qual Outcomes. 2010;3:309-315.
32. de Groote P, Isnard R, Clerson P, Jondeau G, Galinier M, Assyag P, Demil N, Ducardonnet A, Thebaut JF, Komajda M Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: the Impact-Reco Programme. Eur J Heart Fail. 2009;11:85-91.
33. de Peuter OR, Lip GY, Souverein PC, Klungel OH, de BA, Buller HR, Kamphuisen PW Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. Eur J Heart Fail. 2011;13:489-495.
34. Banerjee D, Stafford RS Lack of improvement in outpatient management of congestive heart failure in the United States. Arch Intern Med. 2010; 170:1399-1400.
35. DiMartino LD, Shea AM, Hernandez AF, Curtis LH Use of guidelinerecommended therapies for heart failure in the Medicare population. Clin Cardiol. 2010;33:400-405.
36. Jonsson A, Edner M, Alehagen U, Dahlstrom U Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12:25-31.
37. Dahlstrom U, Hakansson J, Swedberg K, Waldenstrom A Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden. Eur J Heart Fail. 2009;11:92-98.
38. Patel P, White DL, Deswal A Translation of clinical trial results into practice: temporal patterns of 2277;-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J 2007; 153:515-522. (Pubitemid 46440700)
39. Parameswaran AC, Tang WH, Francis GS, Gupta R, Young JB Why do patients fail to receive 2277;-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of 2277;-blocker therapy in patients with chronic heart failure. Am Heart J 2005;149:921-926. (Pubitemid 40718893)
40. Peters-Klimm F, Muller-Tasch T, Remppis A, Szecsenyi J, Schellberg D Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice: results from a cluster-randomized controlled trial of implementation of a clinical practice guideline. J Eval Clin Pract. 2008;14:823-829.
41. Peterson PN, Shetterly SM, Clarke CL, Bekelman DB, Chan PS, Allen LA, Matlock DD, Magid DJ, Masoudi FA Health literacy and outcomes among patients with heart failure. JAMA 2011;305:1695-1701.
42. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. (Pubitemid 29407370)
43. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11-21.
44. CACILtd.ACORNUserGuide.http://www.caci.co.uk/acorn-classification. aspx. 2009. Accessed January 12, 2011.
45. Murray CJ, Frenk J A framework for assessing the performance of health systems. Bull World Health Organ. 2000;78:717-731. (Pubitemid 30489588)
46. Whitehead M, Dahlgren G Concepts and Principles for Tackling Social Inequities in Health: Levelling Up, Part 1. Copenhagen, Denmark: World Health Organization Regional Office for Europe; 2007.
47. Smith GD, Hart C, Watt G, Hole D, Hawthorne V Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health. 1998; 52:399-405. (Pubitemid 28438526)
48. Leyland AH Socioeconomic gradients in the prevalence of cardiovascular disease in Scotland: the roles of composition and context. J Epidemiol Community Health. 2005;59:799-803. (Pubitemid 41176198)
49. Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, Roland M Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355:375-384. (Pubitemid 44127540)
50. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259. (Pubitemid 44079340)
51. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-225. (Pubitemid 40222359)
52. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J The Perindopril in Elderly People With Chronic Heart Failure (PEP-CHF) study. Eur Heart J 2006;27:2338-2345. (Pubitemid 44453578)
53. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781. (Pubitemid 37093918)